Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, August 13, 2018
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Randall Stanicky Upgraded (AMRX) to Buy on, Aug 13th, 2018
Randall Stanicky of RBC Capital, Upgraded "Amneal Pharmaceuticals, Inc." (AMRX) to Buy on, Aug 13th, 2018.
Randall has made no other calls on AMRX in the last 4 months.
There are 3 other peers that have a rating on AMRX. Out of the 3 peers that are also analyzing AMRX, 1 agrees with Randall's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Gary Nachman of "BMO Capital" Maintained at Hold with Increased Target to $20 on, Friday, August 10th, 2018
These are the ratings of the 2 analyists that currently disagree with Randall
- David Risinger of "Morgan Stanley" Initiated at Buy and Held Target at $22 on, Monday, July 23rd, 2018
- David Buck of "B. Riley Securities" Initiated at Strong Buy and Held Target at $26 on, Friday, June 22nd, 2018
